Profit with us in the 2009 bear market
   

Recent Material Events - Biocryst Pharm, Inc (BCRX)

Filing Date Description
2009-10-29 On October 29, 2009, BioCryst Pharmaceuticals, Inc. (the “Company”) issued a news release announcing recent corporate developments and its financial results for the quarter ended September 30, 2009, which also referenced a conference call t ...
2009-10-28 On October 23, 2009, BioCryst Pharmaceuticals, Inc. (the “Company”) issued a press release announcing that the U.S. Food and Drug Administration, in response to a request from the U.S. Centers for Disease Control and Prevention, issued an e ...
2009-09-23 On September 18, 2009, BioCryst Pharmaceuticals, Inc. (the “Company”) entered into a contract modification with the U.S. Department of Health & Human Services (HHS) to advance the development of intravenous (i.v.) peramivir. The modifi ...
2009-07-30 On July 30, 2009, BioCryst Pharmaceuticals, Inc. (the “Company”) issued a news release announcing recent corporate developments and its financial results for the quarter ended May 31, 2009, which also referenced a conference call to discuss ...
2009-05-08 On May 8, 2009, BioCryst Pharmaceuticals, Inc. (the “Company”) issued a news release announcing recent corporate developments and its financial results for the quarter ended March 31, 2009, which also referenced a conference call to discuss ...
2009-03-06 AND ISSUER PURCHASES OF EQUITY SECURITIES ITEM 6. SELECTED FINANCIAL DATA ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF ...
2009-02-06 On February 6, 2009, BioCryst Pharmaceuticals, Inc. (the “Company”) issued a news release announcing its financial results for the quarter and year ended December 31, 2008, which also referenced a conference call to discuss these results an ...
2009-01-28 On January 23, 2009 Randolph C. Steer, M.D., Ph.D., Member of the Board of Directors of BioCryst Pharmaceuticals, Inc. (the “Company”), provided notice to the Company that he has elected not to stand for re-election to the Company’s Bo ...
2008-12-29 BioCryst Pharmaceuticals, Inc. (the “Company”) announced that Stanley C. Erck, 53, has been elected to the Company’s Board of Directors, effective as of December 22, 2008. Mr. Erck has over twenty years of experience in the biotechnolo ...
2008-11-10 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ...
   
 
Home > Companies > Biocryst Pharm, Inc > Recent Material Events
Home | Message boards | Newsletters | Latest Comments | AIM London Stock Exchange | Canadian stocks | Chinese stocks
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2009 hotstocked.com - All rights reserved.